CN107048160A - 一种糖尿病人适用的果蔬米粉制品及其制备方法 - Google Patents
一种糖尿病人适用的果蔬米粉制品及其制备方法 Download PDFInfo
- Publication number
- CN107048160A CN107048160A CN201710295398.XA CN201710295398A CN107048160A CN 107048160 A CN107048160 A CN 107048160A CN 201710295398 A CN201710295398 A CN 201710295398A CN 107048160 A CN107048160 A CN 107048160A
- Authority
- CN
- China
- Prior art keywords
- parts
- rice
- fruits
- vegetables
- applicable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 240000007594 Oryza sativa Species 0.000 title claims abstract description 98
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 98
- 235000009566 rice Nutrition 0.000 title claims abstract description 98
- 235000012055 fruits and vegetables Nutrition 0.000 title claims abstract description 53
- 235000013312 flour Nutrition 0.000 title claims abstract description 51
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims description 13
- 239000000843 powder Substances 0.000 claims abstract description 30
- 240000008042 Zea mays Species 0.000 claims abstract description 29
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 29
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 28
- 235000005822 corn Nutrition 0.000 claims abstract description 28
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 17
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 17
- 239000009636 Huang Qi Substances 0.000 claims abstract description 15
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 14
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 14
- 229920002752 Konjac Polymers 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 229940082787 spirulina Drugs 0.000 claims abstract description 14
- 238000007493 shaping process Methods 0.000 claims abstract description 13
- 239000000419 plant extract Substances 0.000 claims abstract description 12
- 241000208688 Eucommia Species 0.000 claims abstract description 11
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 11
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 241000124033 Salix Species 0.000 claims abstract description 11
- 241000132012 Atractylodes Species 0.000 claims abstract description 10
- 240000004371 Panax ginseng Species 0.000 claims abstract description 10
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 240000002234 Allium sativum Species 0.000 claims abstract description 9
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 9
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims abstract description 9
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims abstract description 9
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims abstract description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 9
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 9
- 235000004611 garlic Nutrition 0.000 claims abstract description 9
- 240000007049 Juglans regia Species 0.000 claims abstract description 8
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 235000020234 walnut Nutrition 0.000 claims abstract description 8
- 239000010977 jade Substances 0.000 claims abstract description 6
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 238000002156 mixing Methods 0.000 claims description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 235000020265 peanut milk Nutrition 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 8
- 229940094952 green tea extract Drugs 0.000 claims description 7
- 235000020688 green tea extract Nutrition 0.000 claims description 7
- 239000008159 sesame oil Substances 0.000 claims description 7
- 235000011803 sesame oil Nutrition 0.000 claims description 7
- 108010038807 Oligopeptides Proteins 0.000 claims description 6
- 102000015636 Oligopeptides Human genes 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000011812 mixed powder Substances 0.000 claims description 4
- 238000010025 steaming Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 3
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 3
- 244000000231 Sesamum indicum Species 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 1
- 210000001161 mammalian embryo Anatomy 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 35
- 239000008280 blood Substances 0.000 abstract description 35
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 22
- 239000008103 glucose Substances 0.000 abstract description 22
- 235000016709 nutrition Nutrition 0.000 abstract description 12
- 230000007774 longterm Effects 0.000 abstract description 5
- 238000007654 immersion Methods 0.000 abstract description 4
- 239000004615 ingredient Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000003801 milling Methods 0.000 abstract description 2
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 235000013305 food Nutrition 0.000 description 18
- 235000019197 fats Nutrition 0.000 description 16
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 15
- 241000219051 Fagopyrum Species 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 235000013339 cereals Nutrition 0.000 description 9
- 230000002218 hypoglycaemic effect Effects 0.000 description 9
- 230000035764 nutrition Effects 0.000 description 9
- 230000000050 nutritive effect Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 230000003712 anti-aging effect Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000011573 trace mineral Substances 0.000 description 7
- 235000013619 trace mineral Nutrition 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 210000000496 pancreas Anatomy 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- -1 triterpene compound Chemical class 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 229920000294 Resistant starch Polymers 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 235000021254 resistant starch Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- CUCUKLJLRRAKFN-UHFFFAOYSA-N 7-Hydroxy-(S)-usnate Chemical compound CC12C(=O)C(C(=O)C)C(=O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O CUCUKLJLRRAKFN-UHFFFAOYSA-N 0.000 description 1
- QFIIYGZAUXVPSZ-UHFFFAOYSA-N 8-(2,4-dihydroxy-6-methylanilino)-2-(2,4-dihydroxy-6-methylphenyl)imino-7-hydroxy-1,9-dimethyldibenzofuran-3-one Chemical compound CC1=CC(=CC(=C1NC2=C(C3=C(C=C2O)OC4=CC(=O)C(=NC5=C(C=C(C=C5C)O)O)C(=C43)C)C)O)O QFIIYGZAUXVPSZ-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001495180 Arthrospira Species 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 1
- 229930182735 Ganoderic acid Natural products 0.000 description 1
- 241001149422 Ganoderma applanatum Species 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 239000004218 Orcein Substances 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241000207961 Sesamum Species 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- VQKFNUFAXTZWDK-UHFFFAOYSA-N alpha-methylfuran Natural products CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- TYPSVDGIQAOBAD-HIFRSBDPSA-N atractylon Natural products Cc1coc2C[C@]3(C)CCCC(=C)[C@H]3Cc12 TYPSVDGIQAOBAD-HIFRSBDPSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000013070 direct material Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000009207 exercise therapy Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019248 orcein Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- ICTZCAHDGHPRQR-UHFFFAOYSA-N usnic acid Natural products OC1=C(C)C(O)=C(C(C)=O)C2=C1C1(C)C(O)=C(C(=O)C)C(=O)C=C1O2 ICTZCAHDGHPRQR-UHFFFAOYSA-N 0.000 description 1
- 229940004858 usnic acid Drugs 0.000 description 1
- WEYVVCKOOFYHRW-UHFFFAOYSA-N usninic acid Natural products CC12C(=O)C(C(=O)C)=C(O)C=C1OC1=C2C(O)=C(C)C(O)=C1C(C)=O WEYVVCKOOFYHRW-UHFFFAOYSA-N 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种糖尿病人适用的果蔬米粉制品,包括以下原料:宜糖米、胚芽米、玉米粉、燕麦粉、蛋白粉、魔芋粉、植物提取物、螺旋藻、荞麦、核桃、海带、卷心菜、香菇、人参果、茯苓、杜仲、白术、琼珍灵芝、黄芪、黄精、山楂、青钱柳叶、玉米须、大蒜;其制作工艺为:浸泡;果蔬打成复合果蔬汁液;药液制备;磨粉;制浆;熟化成型;切条、干燥、包装;得糖尿病人适用的果蔬米粉制品。本发明的果蔬米粉制品,原料配方搭配合理,富含多种人体必需的营养成分,且添加绿色果蔬、中草药成分和调节血糖的植物提取物,不仅营养丰富,而且口感适中,长期食用有扶正固本、调节血糖的功效,适合糖尿病人食用。
Description
技术领域
本发明涉及食品领域,具体涉及一种糖尿病人适用的果蔬米粉制品及其制备方法。
背景技术
糖尿病是一种常见的慢性非传染性疾病,由人体内胰岛素缺乏或功能缺陷所致。糖尿病会导致血液中葡萄糖浓度增高,从而危及体内很多系统,特别是对血管系统和神经系统影响最大。糖尿病可分为Ⅰ型糖尿病、Ⅱ型糖尿病(成年发病型糖尿病)和妊娠期糖尿病,其中Ⅱ型糖尿病最为常见。
据联合国统计,目前全世界有3.5亿人患有糖尿病,其中80%生活在发展中国家。每年有300多万糖尿病患者死于心脏病发作、中风和肾功能衰竭等问题。世界卫生组织预测,到2030年,与糖尿病有关的死亡人数将增加三分之二。由于人口老化和不健康的生活方式全球化的综合因素,这一疾病日益变得更加普遍。
糖尿病人吃什么好呢,这一直是糖尿病患者及其家属比较关心的话题,一个基本的原则就是:可能快速提升血糖的,以及糖分含量高或者淀粉、脂肪含量高的食品是要少吃,他们都很容易转化为葡萄糖。那糖尿病人吃什么好呢?是不是促进血糖降低的就好呢?也不全是。在确诊糖尿病以后,一般都开始吃药来降低血糖,但是药物吃多了不仅会造成身体的负担,也会形成药物依赖性,所以在药物得以控制的情况下,一般坚持使用饮食治疗。
饮食治疗是所有糖尿病人需要坚持的治疗方法。轻型病例以食疗为主即可收到好的效果,中、重型病人,也必须在饮食疗法的基础上,合理应用体疗和药物疗法。只有饮食控制得好,口服降糖药或胰岛胰才能发挥好疗效。否则,一味依赖所谓新药良药而忽略食疗,临床很难取得好的效果。本发明经过长期的实践调配,研究出营养、口感适中的果蔬米粉制品,将多种粗粮、果蔬、中草药成分以及调节血糖的植物提取物与宜糖米等的营养结合,提高了米制品的营养价值且不会造成血糖的快速提升,从而满足了糖尿病人对营养且有养生保健功效的主食的需求,具有重要的现实意义。
发明内容
基于以上所述,本发明的第1个目的在于提供一种糖尿病人适用的果蔬米粉制品。
本发明的第2个目的在于提供上述糖尿病人适用的果蔬米粉制品的制备方法。
为实现上述目的,本发明采取以下技术方案:一种糖尿病人适用的果蔬米粉制品,包括以下原料:宜糖米20-25份、胚芽米12-15份、玉米粉5-8份、燕麦粉6-10份、蛋白粉4-6份、魔芋粉1.5-3份、植物提取物5-8份、螺旋藻2-3份、荞麦2-4份、核桃0.5-1份、海带1-2份、卷心菜1-2份、香菇3-5份、人参果2-3份、茯苓2-3份、杜仲1-2份、白术1-2份、琼珍灵芝1.5-3份、黄芪1-2份、黄精2-3份、山楂0.5-1.5份、青钱柳叶1-2份、玉米须0.5-1份、大蒜0.1-0.3份。
所述蛋白粉选自玉米低聚肽粉和大豆肽粉中的一种或两种。
所述植物提取物选自绿茶提取物、地衣提取物、桑叶提取物中的一种或几种。
上述糖尿病人适用的果蔬米粉制品还包括芝麻油1-2份。
上述糖尿病人适用的果蔬米粉制品的制备方法,包括如下步骤:
(1)浸泡:将所述重量份的宜糖米、胚芽米洗净后混合均匀,用水浸泡1-2h,浸泡温度为25-30℃,过滤至沥干,待用;
(2)果蔬打成复合汁液:按照配方比例称取海带、卷心菜、香菇、人参果,用清水洗净后,将上述所有果蔬切碎混合置于搅拌机中,加入总果蔬重量的3-4倍量水,然后打成混合汁液,过滤得复合果蔬汁液;其中,搅拌机的搅拌速度为500r/min,搅拌时间为15-25min;
(3)药液制备:按配方比例称取茯苓、杜仲、白术、黄芪、黄精、山楂、青钱柳叶、玉米须、大蒜混合后,加入上述总药材重量的10-15倍量水,水中浸泡1-2h,加热至95-105℃,大火煮沸后小火继续煎煮1.5-3h,用4层纱布滤过得药液,加热浓缩至总药材重量的2-4倍,用双层纱布滤过,待用;
(4)磨粉:将螺旋藻、核桃、荞麦用粉碎机粉碎,控制在80-200目筛出粉;
(5)制浆:向步骤(1)所得的沥干的宜糖米混合物中加入步骤(2)所得的复合果蔬汁液、步骤(3)所得的药液和适量水磨浆,得米浆;
(6)熟化成型:将步骤(5)所得的米浆和燕麦粉、蛋白粉、玉米粉、魔芋粉、植物提取物以及步骤(4)所得的混合粉末混合均匀后,再加入芝麻油搅拌均匀,置于蒸粉机的面盘中,控制在110-120℃用蒸汽进行熟化成型;
(7)切条、干燥、包装:成型后按规格进行切条,切条后的米粉经烘干处理后即为糖尿病人适用的果蔬米粉制品,冷却至室温再包装。
所述步骤(1)中宜糖米、胚芽米混合物浸泡所采用的水量为混合物总重量的4-6倍。
所述步骤(5)中米浆的含水量为38-42%。
所述步骤(7)中烘干温度为45-55℃,烘干时间为4-6h。
“宜糖米”是一种纯天然的功能大米。与普通大米相比,“宜糖米”的抗性淀粉含量很高,是普通优质大米20倍以上,粗纤维也高于普通大米,而蛋白质和脂肪相仿。“宜糖米”中丰富的抗性淀粉进入大肠后,在结肠微生物的作用下发酵,形成具有代谢活性的短链脂肪酸(乙酸、丙酸和丁酸等),丙酸具有胰岛素样作用,可刺激糖酵解、激活离体肝细胞的糖原合成、减少糖异生,从而降低血糖。因此,食用“宜糖米”,不仅一日三餐可满足对抗性淀粉的保健需求,也如普通大米一样可充分满足正常的营养需求。“宜糖米”是所有追求健康人士的保健膳食,食用“宜糖米”能补充人体必需的抗性淀粉,能从源头途径预防糖尿病、三高、肥胖和心脑血管等疾病,有利于肠道健康、防止便秘和结肠癌,能使广大追求健康人士在一日三餐间轻松保健。
胚芽米是保留米的胚芽部分,其他部分则与白米完全相同的一种米。由胚芽米机碾磨水稻生产出来,不同的胚芽米机胚芽米保留胚芽率不同,一般在60%-70%左右。胚芽米真正作到保全糙米营养,并留存新米的鲜香。其富含人体所需的蛋白质、淀粉、B族维生素、矿物质、膳食纤维,以及丰富的钙、铁、锌等微量元素,营养价值极高,具有能排泄体内的有毒物质,辅助其他营养素的吸收,培育对人体有益的细菌,合成维他命,抵制对人体有害的恶菌,解除便秘,减低大肠的内压,降低胆固醇与中性脂肪的血中浓度,预防与改善肥胖,使血糖值正常化,能适当均衡地摄取微量元素等作用。
玉米含有丰富的营养素。在美国和其他一些发达国家,玉米已被列为谷类食物中的首位保健食品,被称为“黄金作物”。经研究发现玉米中含有大量的卵磷脂、亚油酸、谷物醇、维生素E、纤维素等,具有降血压、降血脂、抗动脉硬化、预防肠癌、美容养颜、延缓衰老等多种保健功效,也是糖尿病人的适宜佳品。
燕麦粉,是由去壳燕麦制成的面粉高度精制而成的。不含胆固醇,带有全谷物类的少量脂肪,富含丰富的营养素,如维生素、蛋白质、微量元素、纤维素等。具有降低血胆固醇,降低心血管疾病,控制血糖,改善便秘,促进伤口愈合,预防更年期障碍,预防骨质疏松,预防贫血、控制体重等功用。
玉米低聚肽粉作为玉米蛋白经过酶降解而获得的多种小肽的混合物,除具有肽类物质的优良特性——优于氨基酸或蛋白质的直接吸收、溶解性强、稳定性强、安全性高等特性以外,还具有自己所独有的特殊功效。
大豆肽粉是一种由2-6个氨基酸组成的、分子量在200-800Dalton的混合肽产品。与原蛋白相比,大豆肽粉具有很好的水溶性、持水性、起泡性,能在pH2-10的任何酸碱条件下完全溶解。大豆肽粉能与其它食品配料完全溶合,并保持各自原有的物化及营养特性。与原蛋白和同组成的氨基酸制剂相比,大豆肽粉更易被人体吸收,它可不经胃肠消化,直接进入小肠被吸收,而且不受身体状况所影响。大豆肽粉含有多种生物活性肽,具有多种生理活性,包括抗氧化、降血压、降低胆固醇、降血脂、抗疲劳、抗衰老、保护表皮细胞、防止黑色素沉着、增强免疫等。作为一种新型多功能营养配料,大豆肽粉可广泛地用于保健食品、婴幼儿食品、运动食品、发酵制品及临床营养制剂等。
魔芋,它是一种根茎植物,含有葡萄甘露聚糖,是一种高分子化合物,具有很强的吸水性,吸水后体积可膨胀80-100倍,食后易被消化吸收。经研究证明它具有降脂、降糖、防癌、通便等多种功用;并能吸附胆固醇和胆汁酸,对降低血压,减少心血管病发作有一定效用。魔芋还含有可溶性膳食纤维,这种纤维对抑制餐后血糖升高很有效,因而魔芋精粉及其制品都是糖尿病患者理想的降糖食品;应用后可减轻胰岛负担。魔芋具有多种防病保健功用,经常食用魔芋食品对身体大有好处。
绿茶提取物:绿茶提取物含有一定量的茶多酚和咖啡因,茶多酚具有抗氧化、防癌、抗肿瘤、抗辐射、抗病毒、增强机体抵抗力、降血糖和血脂、预防心血管疾病等作用。而所含天然的咖啡因,有减少疲劳,增强身体的耐力的作用。
地衣营养价值较高,内含多种氨基酸,铜、镁等微量营养素,矿物质,松萝酸、地衣硬酸以及地衣二酚的多种缩合物,其具有提高免疫力,高度的抗癌活性,祛脂降压,消炎、清热解毒,明目等功能;且钙含量之高是蔬菜中少见的。
桑叶提取物中含有桑叶黄酮、桑叶多酚、桑叶多糖、DNJ、GABA等多种生理活性物质,用于防治心脑血管病、高脂血症、糖尿病、肥胖症和抗衰老等。其脱氧野尻霉素与葛根提取类黄酮物质结合形成一种新物质——洗胰清糖素(cics),适合用于治降血糖、血脂、抗炎等。
螺旋藻:亦称“节旋藻”。螺旋藻营养成分中蛋白质含量高,而脂肪、纤维素含量低,并且还含有种类繁多的维生素,它是维生素B12和β-胡萝卜素含量最高的食品。螺旋藻还是叶绿素的天然宝库,量多质优,占藻体的1.1%,是大多数陆生植物的2~3倍,是普通蔬菜的10倍;螺旋藻所含叶绿素的类型主要是叶绿素a,分子结构与人的血红素十分相似,是人类合成血红蛋白的直接原料,堪称“绿色血液”。此外,它还是所有食物中可吸收性铁质含量最高的,同时还发现它含有具有防癌、治癌作用的藻类蛋白,以及其他大量矿质元素和提高机体免疫力的生物活性物质。因此,螺旋藻具有降低胆固醇,调节血糖,增强免疫系统,保护肠胃,抗肿瘤、防癌抑癌,防治高脂血症,抗氧化、抗衰老、抗疲劳,抗辐射,治疗贫血症等保健功效。
荞麦蛋白质中含有丰富的赖氨酸成分,铁、锰、锌等微量元素比一般谷物丰富,而且含有丰富膳食纤维,是一般精制大米的10倍,所以荞麦具有很好的营养保健作用。荞麦含有丰富的维生素E和可溶性膳食纤维,同时还含有烟酸和芦丁,芦丁有降低人体血脂和胆固醇、软化血管、保护视力和预防脑血管出血的作用;它含有的烟酸成分能促进机体的新陈代谢,增强解毒能力,还具有扩张小血管和降低血液胆固醇的作用。荞麦含有丰富的镁,能促进人体纤维蛋白溶解,使血管扩张,抑制凝血块的形成,具有抗栓塞的作用,也有利于降低血清胆固醇。荞麦的碳水化合物主要是淀粉,因为颗粒较细小,所以和其他谷类相比,具有容易煮熟、容易消化、容易加工的特点。荞麦中的某些黄酮成分还具有抗菌、消炎、止咳、平喘、祛痰的作用。因此,荞麦还有“消炎粮食”的美称。另外这些成分还具有降低血糖的功效。祖国医学认为,荞麦性味甘平,有健脾益气、开胃宽肠、消食化滞的功效。
香菇又名冬菇、香蕈、北菇、厚菇、薄菇、花菇、椎茸,是一种食用真菌。香菇含有多种维生素、多种氨基酸、多糖、矿物质,是具有高蛋白、低脂肪的菌类食物;素有“真菌皇后”之称;对促进人体新陈代谢,提高机体适应力有很大作用。香菇还对糖尿病、肺结核、传染性肝炎、神经炎等起治疗作用,又可用于消化不良、便秘、减肥等。中国不少古籍中记载香菇“益气不饥,治风破血和益胃助食”。民间用来助痘疮、麻疹的诱发,治头痛、头晕。同时香菇中含有嘌呤、胆碱、酪氨酸、氧化酶以及某些核酸物质,可降血压、降血脂、降胆固醇;还具有防癌抗癌等功效。
人参果:又名长寿果、凤果、艳果,亦可称仙果、香艳梨、艳果;属茄科类多年生双子叶草本植物。其果肉清香多汁,腹内无核,风味独特,具有高蛋白、低脂肪、低糖、等特点,同时富含蛋白质、氨基酸以及微量元素、维生素与矿物元素,具有强身健体、防治疾病、益寿延年、抗衰老、降血压、降血糖、美容等保健功效。它是一种营养较为全面的蔬果两用食品。食用能补充人体所需,具有营养保健价值。
茯苓,又称玉灵、茯灵、万灵桂、茯菟。是拟层孔菌科真菌茯苓的干燥菌核,外皮淡棕色或黑褐色,内部粉色或白色,精制后称为白茯苓或者云苓。具有宁心安神、败毒抗癌、抑制胃酸分泌、增强免疫力、抗菌、抗肿瘤以及镇静、降血糖等的作用。药性平和,利湿而不伤正气。适量服食可作为春夏潮湿季节的调养佳品。
杜仲:又名胶木,是中国名贵滋补药材。其味甘,性温。有补益肝肾、强筋壮骨、调理冲任、固经安胎的功效。可治疗肾阳虚引起的腰腿痛或酸软无力,肝气虚引起的胞胎不固,阴囊湿痒等症。在《神农本草经》中被列为上品。现代研究杜仲具有清除体内垃圾,加强人体细胞物质代谢,防止肌肉骨骼老化,平衡人体血压,分解体内胆固醇,降低体内脂肪,恢复血管弹性,利尿清热,广谱抗菌,兴奋中枢神经,提高白血球等药理作用。
白术:苦、甘,温;归脾、胃经;其含挥发油1.4%,主要成分为苍术醇(Atractylol)、苍术酮(Atractylon)等,并含有维生素A。具体补脾,益胃,燥湿,和中,安胎功效。治脾胃气弱,不思饮食,倦怠少气,虚胀,泄泻,痰饮,水肿,黄疸,湿痹,小便不利,头晕,自汗,胎气不安。
琼珍灵芝是天然纯正地道的“林中灵”林下灵芝,被誉为“灵芝中的灵芝”,具有非常高的药用价值。琼珍灵芝含有200多种高分子多糖体,可防治肿瘤、糖尿病,早衰,高血压、过敏疾病,肝脏疾病,以及促进免疫功能改善。它还含有包括人体所必需的20多种氨基酸,以及具有药理活性的化学物质:如生物碱、腺甘、麦角甾醇、微量元素、三萜类化合物等,尤其三萜类化合物里的灵芝酸,能有效的降血脂、降血糖、平稳血压,而灵芝中各种有效成分之间,具有协同作用。药典中记载“灵芝扶正固本,可医治百病”在现代研究中发现:琼珍灵芝是通过激发、调节,增强人体的免疫力和自愈力的功能来抵抗疾病,适合糖尿病、高血压、高血脂、肿瘤、失眠等慢性病的治疗和调养。
黄芪,又名绵芪,味甘,性微温。黄芪是百姓经常食用的纯天然品,民间流传着“常喝黄芪汤,防病保健康”的顺口溜,意思是说经常用黄芪煎汤或泡水代茶饮,具有良好的防病保健作用。现代医学研究表明,黄芪有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。黄芪不仅能扩张冠状动脉,改善心肌供血,提高免疫功能,而且能够延缓细胞衰老的进程。黄芪食用方便,可煎汤,煎膏,浸酒,入菜肴等。
黄精味甘,性平。可作久服滋补之品,是生活中常见的中草药,含有多种对人体有益的化学成分,如多糖,甾体皂苷,蒽醌类,生物碱,强心苷,木脂素,维生素,氨基酸和锌、铜、铁等,有补气养阴,健脾益肾,补肝气的功效;还有抗缺氧、抗疲劳、抗衰老作用;能增强免疫功能,增强新陈代谢;有降血糖和强心作用。
青钱柳富含丰富的皂苷、黄酮、多糖等有机营养成分,且含有大量的铁、锌、硒、铬、锗、镁、钙等无机营养成分,还含有锰、铁、铜、铬、锌、硒、钒、锗等微量元素,与糖代谢和胰岛素作用密切相关的元素Ni、Cr、V、Se的含量较高,其无机营养成分跟有机营养成分,能够有效协助胰岛素发挥降血糖作用,改善糖耐量,平衡人体糖代谢,从而达到降血糖,逆转并发症的养生效果。《全国中草药名鉴》记载:“青钱柳树皮、叶、根有杀虫止痒,消炎止痛祛风之功效。”中医临床用于治疗糖尿病,因其有药理作用能明显降低血糖、减脂肪和尿糖。
玉米须为禾本科植物玉蜀黍的花柱和柱头,味甘、淡,性平。有利尿消肿,清肝利胆的功效。主治水肿,小便淋沥,黄疸,胆囊炎,胆结石,高血压,糖尿病,乳汁不通。
本发明的有益效果:本发明的果蔬复合养颜米粉属于一种保健食品,原料配方搭配合理,富含多种人体必需的营养成分,将多种粗粮、绿色果蔬、中草药成分以及调节血糖的植物提取物与宜糖米等的营养结合,提高了米制品的营养价值且不会造成血糖的快速提升,不仅营养丰富,而且口感适中,长期食用有扶正固本、调节血糖的功效,从而满足了糖尿病人对营养且有养生保健功效的主食的需求,具有重要的现实意义。
具体实施方式
以下对本发明的具体实施方式进行详细说明。应当理解的是,此处所描述的具体实施方式仅用于说明和解释本发明,并不局限于这些实施例。实施例中,玉米低聚肽粉、大豆肽粉、绿茶提取物、地衣提取物、桑叶提取物为盖德化工网产品,其他原料为市售产品。
实施例1
一种糖尿病人适用的果蔬米粉制品,包括以下原料:
宜糖米22份、胚芽米13份、玉米粉7份、燕麦粉8份、玉米低聚肽粉4份、大豆肽粉2份、魔芋粉2份、绿茶提取物3份、地衣提取物2份、桑叶提取物中2份、螺旋藻2份、荞麦3份、核桃0.5份、海带2份、卷心菜2份、香菇4份、人参果3份、茯苓2.5份、杜仲2份、白术2份、琼珍灵芝2份、黄芪2份、黄精2.5份、山楂1份、青钱柳叶1.5份、玉米须0.8份、大蒜0.2份、芝麻油2份。
上述糖尿病人适用的果蔬米粉制品的制备方法,包括如下步骤:
(1)浸泡:将所述重量份的宜糖米、胚芽米洗净后混合均匀,用水浸泡1-2h,浸泡温度为25-30℃,过滤至沥干,待用;
(2)果蔬打成复合汁液:按照配方比例称取海带、卷心菜、香菇、人参果,用清水洗净后,将上述所有果蔬切碎混合置于搅拌机中,加入总果蔬重量的3-4倍量水,然后打成混合汁液,过滤得复合果蔬汁液;其中,搅拌机的搅拌速度为500r/min,搅拌时间为15-25min;
(3)药液制备:按配方比例称取茯苓、杜仲、白术、黄芪、黄精、山楂、青钱柳叶、玉米须、大蒜混合后,加入上述总药材重量的10-15倍量水,水中浸泡1-2h,加热至95-105℃,大火煮沸后小火继续煎煮1.5-3h,用4层纱布滤过得药液,加热浓缩至总药材重量的2-4倍,用双层纱布滤过,待用;
(4)磨粉:将螺旋藻、核桃、荞麦用粉碎机粉碎,控制在80-200目筛出粉;
(5)制浆:向步骤(1)所得的沥干的宜糖米混合物中加入步骤(2)所得的复合果蔬汁液、步骤(3)所得的药液和适量水磨浆,得米浆;
(6)熟化成型:将步骤(5)所得的米浆和燕麦粉、蛋白粉、玉米粉、魔芋粉、植物提取物以及步骤(4)所得的混合粉末混合均匀后,再加入芝麻油搅拌均匀,置于蒸粉机的面盘中,控制在110-120℃用蒸汽进行熟化成型;
(7)切条、干燥、包装:成型后按规格进行切条,切条后的米粉经烘干处理后即为糖尿病人适用的果蔬米粉制品,冷却至室温再包装。
实施例2
一种糖尿病人适用的果蔬米粉制品,包括以下原料:
宜糖米25份、胚芽米13份、玉米粉6份、燕麦粉8份、玉米低聚肽粉4份、大豆肽粉1份、魔芋粉2.5份、绿茶提取物3份、地衣提取物2份、桑叶提取物3份、螺旋藻2.5份、荞麦3份、核桃0.5份、海带1.5份、卷心菜1.5份、香菇4份、人参果3份、茯苓2份、杜仲2份、白术1.5份、琼珍灵芝2.5份、黄芪1.5份、黄精2份、山楂0.5份、青钱柳叶1.5份、玉米须0.7份、大蒜0.3份、芝麻油2份。
上述糖尿病人适用的果蔬米粉制品的制备方法,包括如下步骤:
(1)浸泡:将所述重量份的宜糖米、胚芽米洗净后混合均匀,用水浸泡1-2h,浸泡温度为25-30℃,过滤至沥干,待用;
(2)果蔬打成复合汁液:按照配方比例称取海带、卷心菜、香菇、人参果,用清水洗净后,将上述所有果蔬切碎混合置于搅拌机中,加入总果蔬重量的3-4倍量水,然后打成混合汁液,过滤得复合果蔬汁液;其中,搅拌机的搅拌速度为500r/min,搅拌时间为15-25min;
(3)药液制备:按配方比例称取茯苓、杜仲、白术、黄芪、黄精、山楂、青钱柳叶、玉米须、大蒜混合后,加入上述总药材重量的10-15倍量水,水中浸泡1-2h,加热至95-105℃,大火煮沸后小火继续煎煮1.5-3h,用4层纱布滤过得药液,加热浓缩至总药材重量的2-4倍,用双层纱布滤过,待用;
(4)磨粉:将螺旋藻、核桃、荞麦用粉碎机粉碎,控制在80-200目筛出粉;
(5)制浆:向步骤(1)所得的沥干的宜糖米混合物中加入步骤(2)所得的复合果蔬汁液、步骤(3)所得的药液和适量水磨浆,得米浆;
(6)熟化成型:将步骤(5)所得的米浆和燕麦粉、蛋白粉、玉米粉、魔芋粉、植物提取物以及步骤(4)所得的混合粉末混合均匀后,再加入芝麻油搅拌均匀,置于蒸粉机的面盘中,控制在110-120℃用蒸汽进行熟化成型;
(7)切条、干燥、包装:成型后按规格进行切条,切条后的米粉经烘干处理后即为糖尿病人适用的果蔬米粉制品,冷却至室温再包装。
综合效果调查:
以下选取糖尿病志愿者共60人,任意等分成三组,分别食用实施例1、2和普通大米,进行未食用前与食用两个小时后的血糖变化值检测以及食用口感的询问,检测和询问结果见下表:
综上所述,本发明所制得的果蔬米粉制品食用前后血糖变化小,且口感较好,将多种粗粮、绿色果蔬、中草药成分以及调节血糖的植物提取物与宜糖米等的营养结合,提高了米制品的营养价值且不会造成血糖的快速提升,长期食用有扶正固本、调节血糖的功效,从而满足了糖尿病人对营养且有养生保健功效的主食的需求。
Claims (8)
1.一种糖尿病人适用的果蔬米粉制品,其特征在于,包括以下原料:宜糖米20-25份、胚芽米12-15份、玉米粉5-8份、燕麦粉6-10份、蛋白粉4-6份、魔芋粉1.5-3份、植物提取物5-8份、螺旋藻2-3份、荞麦2-4份、核桃0.5-1份、海带1-2份、卷心菜1-2份、香菇3-5份、人参果2-3份、茯苓2-3份、杜仲1-2份、白术1-2份、琼珍灵芝1.5-3份、黄芪1-2份、黄精2-3份、山楂0.5-1.5份、青钱柳叶1-2份、玉米须0.5-1份、大蒜0.1-0.3份。
2.根据权利要求1所述的一种糖尿病人适用的果蔬米粉制品,其特征在于:所述蛋白粉选自玉米低聚肽粉和大豆肽粉中的一种或两种。
3.根据权利要求1所述的一种糖尿病人适用的果蔬米粉制品,其特征在于:所述植物提取物选自绿茶提取物、地衣提取物、桑叶提取物中的一种或几种。
4.根据权利要求1所述的一种糖尿病人适用的果蔬米粉制品,其特征在于:还包括芝麻油1-2份。
5.权利要求1所述的一种糖尿病人适用的果蔬米粉制品的制备方法,其特征在于,包括如下步骤:
(1)浸泡:将所述重量份的宜糖米、胚芽米洗净后混合均匀,用水浸泡1-2h,浸泡温度为25-30℃,过滤至沥干,待用;
(2)果蔬打成复合汁液:按照配方比例称取海带、卷心菜、香菇、人参果,用清水洗净后,将上述所有果蔬切碎混合置于搅拌机中,加入总果蔬重量的3-4倍量水,然后打成混合汁液,过滤得复合果蔬汁液;其中,搅拌机的搅拌速度为500r/min,搅拌时间为15-25min;
(3)药液制备:按配方比例称取茯苓、杜仲、白术、黄芪、黄精、山楂、青钱柳叶、玉米须、大蒜混合后,加入上述总药材重量的10-15倍量水,水中浸泡1-2h,加热至95-105℃,大火煮沸后小火继续煎煮1.5-3h,用4层纱布滤过得药液,加热浓缩至总药材重量的2-4倍,用双层纱布滤过,待用;
(4)磨粉:将螺旋藻、核桃、荞麦用粉碎机粉碎,控制在80-200目筛出粉;
(5)制浆:向步骤(1)所得的沥干的宜糖米混合物中加入步骤(2)所得的复合果蔬汁液、步骤(3)所得的药液和适量水磨浆,得米浆;
(6)熟化成型:将步骤(5)所得的米浆和燕麦粉、蛋白粉、玉米粉、魔芋粉、植物提取物以及步骤(4)所得的混合粉末混合均匀后,再加入芝麻油搅拌均匀,置于蒸粉机的面盘中,控制在110-120℃用蒸汽进行熟化成型;
(7)切条、干燥、包装:成型后按规格进行切条,切条后的米粉经烘干处理后即为糖尿病人适用的果蔬米粉制品,冷却至室温再包装。
6.根据权利要求5所述的一种糖尿病人适用的果蔬米粉制品的制备方法,其特征在于:所述步骤(1)中宜糖米、胚芽米混合物浸泡所采用的水量为混合物总重量的4-6倍。
7.根据权利要求5所述的一种糖尿病人适用的果蔬米粉制品的制备方法,其特征在于:所述步骤(5)中米浆的含水量为38-42%。
8.根据权利要求5所述的一种糖尿病人适用的果蔬米粉制品的制备方法,其特征在于:所述步骤(7)中烘干温度为45-55℃,烘干时间为4-6h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710295398.XA CN107048160A (zh) | 2017-04-28 | 2017-04-28 | 一种糖尿病人适用的果蔬米粉制品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710295398.XA CN107048160A (zh) | 2017-04-28 | 2017-04-28 | 一种糖尿病人适用的果蔬米粉制品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107048160A true CN107048160A (zh) | 2017-08-18 |
Family
ID=59605150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710295398.XA Withdrawn CN107048160A (zh) | 2017-04-28 | 2017-04-28 | 一种糖尿病人适用的果蔬米粉制品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107048160A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108522970A (zh) * | 2018-04-17 | 2018-09-14 | 浙江海洋大学 | 一种海藻类原料制成的糖尿病全营养配方食品及其制备方法 |
CN110301583A (zh) * | 2019-08-16 | 2019-10-08 | 桂林老盐街餐饮有限公司 | 富含微量元素硒的罗汉果米粉干粉及其制备方法 |
CN114451521A (zh) * | 2022-03-04 | 2022-05-10 | 辽宁童子健康科技有限公司 | 一种适合糖尿病人养生的保健米/米粉及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101263882A (zh) * | 2007-03-13 | 2008-09-17 | 曹誉百 | 一种瓜果、蔬菜米粉及其制备方法 |
CN103445061A (zh) * | 2013-08-01 | 2013-12-18 | 安徽康圣食品科技有限公司 | 一种具有三降作用的糯米粉及其制备方法 |
CN104336450A (zh) * | 2014-09-28 | 2015-02-11 | 安徽光明槐祥工贸集团有限公司 | 一种有效缓解糖尿病的糯米粉的制备方法 |
CN105231258A (zh) * | 2015-08-27 | 2016-01-13 | 安徽倮倮米业有限公司 | 一种无糖高钙营养米粉及其制备方法 |
-
2017
- 2017-04-28 CN CN201710295398.XA patent/CN107048160A/zh not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101263882A (zh) * | 2007-03-13 | 2008-09-17 | 曹誉百 | 一种瓜果、蔬菜米粉及其制备方法 |
CN103445061A (zh) * | 2013-08-01 | 2013-12-18 | 安徽康圣食品科技有限公司 | 一种具有三降作用的糯米粉及其制备方法 |
CN104336450A (zh) * | 2014-09-28 | 2015-02-11 | 安徽光明槐祥工贸集团有限公司 | 一种有效缓解糖尿病的糯米粉的制备方法 |
CN105231258A (zh) * | 2015-08-27 | 2016-01-13 | 安徽倮倮米业有限公司 | 一种无糖高钙营养米粉及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108522970A (zh) * | 2018-04-17 | 2018-09-14 | 浙江海洋大学 | 一种海藻类原料制成的糖尿病全营养配方食品及其制备方法 |
CN110301583A (zh) * | 2019-08-16 | 2019-10-08 | 桂林老盐街餐饮有限公司 | 富含微量元素硒的罗汉果米粉干粉及其制备方法 |
CN114451521A (zh) * | 2022-03-04 | 2022-05-10 | 辽宁童子健康科技有限公司 | 一种适合糖尿病人养生的保健米/米粉及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN104435775B (zh) | 一种中药保健酒及其制备方法 | |
CN103099089B (zh) | 一种降糖、降压、通便减肥、抗疲劳、改善性功能保健品及其生产工艺 | |
CN101637255B (zh) | 一种降糖营养粉 | |
CN101181058B (zh) | 增强人体五脏机能的五行果蔬营养制剂及其制备方法 | |
CN103749817A (zh) | 一种栀子茶及其制备方法 | |
CN102524659A (zh) | 一种具有营养保健功能的粮食配方 | |
CN102919450B (zh) | 一种五谷浸提液凉茶及其制备方法 | |
CN101664175A (zh) | 一种天然五彩杂粮果蔬茶粥及制作方法 | |
CN107114663A (zh) | 一种果蔬养胃米粉及其制备方法 | |
CN109966417A (zh) | 一种针对糖尿病人群的固体饮料 | |
CN101664174A (zh) | 一种天然五彩养脏杂粮瓜菜粥及制作方法 | |
CN109007856A (zh) | 一种适合高血压、高血脂、高血糖和高尿酸人群服用的代餐粉及制备方法 | |
CN106720787A (zh) | 一种降糖降压保健茶及其制备方法 | |
CN110051815A (zh) | 一种辅助降血糖食丸及其制备方法 | |
CN106974174A (zh) | 一种果蔬复合米粉及其制备方法 | |
CN108991078A (zh) | 一种防控富贵病的桑叶食品及其制备方法 | |
CN107223846A (zh) | 一种适合中老年人的杂粮保健粉 | |
CN107048160A (zh) | 一种糖尿病人适用的果蔬米粉制品及其制备方法 | |
CN103478560B (zh) | 一种用牛奶和绞股蓝制造的营养大米 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN104544084B (zh) | 一种用于糖尿病患者的保健食品 | |
CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
CN106135525A (zh) | 一种袋泡核桃红茶及其制备方法 | |
CN105815738A (zh) | 一种辅助降血糖的制品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170818 |